Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient

To report a case of reduced duration of action of rocuronium in a patient with normocalcemic hyperparathyroidism (HPT). A 56-yr-old patient with primary HPT, who had had surgical resection of three and a half parathyroid glands nine months previously, was referred to our institution for further inve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Canadian journal of anesthesia 2003-06, Vol.50 (6), p.558-561
Hauptverfasser: MUNIR, Muhammad A, JAFFAR, Muhammad, ARSHAD, Muhammad, AKHTER, M. Shahab, JUNMING ZHANG
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 561
container_issue 6
container_start_page 558
container_title Canadian journal of anesthesia
container_volume 50
creator MUNIR, Muhammad A
JAFFAR, Muhammad
ARSHAD, Muhammad
AKHTER, M. Shahab
JUNMING ZHANG
description To report a case of reduced duration of action of rocuronium in a patient with normocalcemic hyperparathyroidism (HPT). A 56-yr-old patient with primary HPT, who had had surgical resection of three and a half parathyroid glands nine months previously, was referred to our institution for further investigation of a persistent increase in parathyroid hormone. Preoperatively, the patient had a normal serum ionized and total calcium. The patient was diagnosed with a persistent parathyroid adenoma and was scheduled for an elective parathyroidectomy. General anesthesia was induced with iv propofol, fentanyl and succinylcholine. Intraoperatively, anesthesia was maintained with nitrous oxide in oxygen, and isoflurane. Neuromuscular blockade was attained using incremental doses of rocuronium. The average duration of 0.15 mg x kg(-1) incremental doses of rocuronium was 5.9 min (expected: 13-18 min), and that of 0.2 mg x kg(-1) was ten minutes (expected: 19-23 min). Primary HPT even in the absence of hypercalcemia may result in resistance to competitive blockade by rocuronium. It suggests that primary HPT may cause acetylcholine receptor up-regulation resulting in hyposensitivity to non-depolarizing muscle relaxants.
doi_str_mv 10.1007/BF03018640
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73400155</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73400155</sourcerecordid><originalsourceid>FETCH-LOGICAL-c376t-56d90979aba6b378d86263c49a045e26cc891859675b0911a3db65a770da4c743</originalsourceid><addsrcrecordid>eNpd0E1r3DAQBmBRUppNmkt_QBGF5FBwOrKsr2MSkrQQKIQUejNjScsq2JYrWTT77-OwCws5DQzPvAwvIV8YXDIA9eP6DjgwLRv4QFasMbLSRokjsgLN60oy-HtMTnJ-BgAthf5EjlmtaykauSL46F2x3lFXEs4hjjSu6VCy7T1NvseX3fJ_mDc0RVtSHEMZaBgp0jGmIVrsrR-CpZvt5NOES8pmm2JwdFpO_Th_Jh_X2Gd_tp-n5M_d7dPNz-rh9_2vm6uHynIl50pIZ8Aogx3KjivttKwlt41BaISvpbXaMC2MVKIDwxhy10mBSoHDxqqGn5KLXe6U4r_i89wOIVvf9zj6WHKreAPAhFjgt3fwOZY0Lr-1WjOuBBNqQd93yKaYc_LrdkphwLRtGbRvrbeH1hf8dZ9YusG7A93XvIDzPcC8FLZOONqQD06wWtZa8FeiK4lX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>881375157</pqid></control><display><type>article</type><title>Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>MUNIR, Muhammad A ; JAFFAR, Muhammad ; ARSHAD, Muhammad ; AKHTER, M. Shahab ; JUNMING ZHANG</creator><creatorcontrib>MUNIR, Muhammad A ; JAFFAR, Muhammad ; ARSHAD, Muhammad ; AKHTER, M. Shahab ; JUNMING ZHANG</creatorcontrib><description>To report a case of reduced duration of action of rocuronium in a patient with normocalcemic hyperparathyroidism (HPT). A 56-yr-old patient with primary HPT, who had had surgical resection of three and a half parathyroid glands nine months previously, was referred to our institution for further investigation of a persistent increase in parathyroid hormone. Preoperatively, the patient had a normal serum ionized and total calcium. The patient was diagnosed with a persistent parathyroid adenoma and was scheduled for an elective parathyroidectomy. General anesthesia was induced with iv propofol, fentanyl and succinylcholine. Intraoperatively, anesthesia was maintained with nitrous oxide in oxygen, and isoflurane. Neuromuscular blockade was attained using incremental doses of rocuronium. The average duration of 0.15 mg x kg(-1) incremental doses of rocuronium was 5.9 min (expected: 13-18 min), and that of 0.2 mg x kg(-1) was ten minutes (expected: 19-23 min). Primary HPT even in the absence of hypercalcemia may result in resistance to competitive blockade by rocuronium. It suggests that primary HPT may cause acetylcholine receptor up-regulation resulting in hyposensitivity to non-depolarizing muscle relaxants.</description><identifier>ISSN: 0832-610X</identifier><identifier>EISSN: 1496-8975</identifier><identifier>DOI: 10.1007/BF03018640</identifier><identifier>PMID: 12826546</identifier><identifier>CODEN: CJOAEP</identifier><language>eng</language><publisher>Toronto, ON: Canadian Anesthesiologists' Society</publisher><subject>Androstanols - pharmacology ; Anesthesia ; Anesthetics. Neuromuscular blocking agents ; Biological and medical sciences ; Female ; Humans ; Medical sciences ; Middle Aged ; Muscle Relaxation - drug effects ; Neuromuscular Nondepolarizing Agents - pharmacology ; Neuropharmacology ; Pharmacology. Drug treatments ; Receptors, Cholinergic - analysis ; Receptors, Cholinergic - drug effects ; Time Factors</subject><ispartof>Canadian journal of anesthesia, 2003-06, Vol.50 (6), p.558-561</ispartof><rights>2003 INIST-CNRS</rights><rights>Canadian Anesthesiologists 2003.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c376t-56d90979aba6b378d86263c49a045e26cc891859675b0911a3db65a770da4c743</citedby><cites>FETCH-LOGICAL-c376t-56d90979aba6b378d86263c49a045e26cc891859675b0911a3db65a770da4c743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15126285$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12826546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MUNIR, Muhammad A</creatorcontrib><creatorcontrib>JAFFAR, Muhammad</creatorcontrib><creatorcontrib>ARSHAD, Muhammad</creatorcontrib><creatorcontrib>AKHTER, M. Shahab</creatorcontrib><creatorcontrib>JUNMING ZHANG</creatorcontrib><title>Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient</title><title>Canadian journal of anesthesia</title><addtitle>Can J Anaesth</addtitle><description>To report a case of reduced duration of action of rocuronium in a patient with normocalcemic hyperparathyroidism (HPT). A 56-yr-old patient with primary HPT, who had had surgical resection of three and a half parathyroid glands nine months previously, was referred to our institution for further investigation of a persistent increase in parathyroid hormone. Preoperatively, the patient had a normal serum ionized and total calcium. The patient was diagnosed with a persistent parathyroid adenoma and was scheduled for an elective parathyroidectomy. General anesthesia was induced with iv propofol, fentanyl and succinylcholine. Intraoperatively, anesthesia was maintained with nitrous oxide in oxygen, and isoflurane. Neuromuscular blockade was attained using incremental doses of rocuronium. The average duration of 0.15 mg x kg(-1) incremental doses of rocuronium was 5.9 min (expected: 13-18 min), and that of 0.2 mg x kg(-1) was ten minutes (expected: 19-23 min). Primary HPT even in the absence of hypercalcemia may result in resistance to competitive blockade by rocuronium. It suggests that primary HPT may cause acetylcholine receptor up-regulation resulting in hyposensitivity to non-depolarizing muscle relaxants.</description><subject>Androstanols - pharmacology</subject><subject>Anesthesia</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Muscle Relaxation - drug effects</subject><subject>Neuromuscular Nondepolarizing Agents - pharmacology</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Receptors, Cholinergic - analysis</subject><subject>Receptors, Cholinergic - drug effects</subject><subject>Time Factors</subject><issn>0832-610X</issn><issn>1496-8975</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0E1r3DAQBmBRUppNmkt_QBGF5FBwOrKsr2MSkrQQKIQUejNjScsq2JYrWTT77-OwCws5DQzPvAwvIV8YXDIA9eP6DjgwLRv4QFasMbLSRokjsgLN60oy-HtMTnJ-BgAthf5EjlmtaykauSL46F2x3lFXEs4hjjSu6VCy7T1NvseX3fJ_mDc0RVtSHEMZaBgp0jGmIVrsrR-CpZvt5NOES8pmm2JwdFpO_Th_Jh_X2Gd_tp-n5M_d7dPNz-rh9_2vm6uHynIl50pIZ8Aogx3KjivttKwlt41BaISvpbXaMC2MVKIDwxhy10mBSoHDxqqGn5KLXe6U4r_i89wOIVvf9zj6WHKreAPAhFjgt3fwOZY0Lr-1WjOuBBNqQd93yKaYc_LrdkphwLRtGbRvrbeH1hf8dZ9YusG7A93XvIDzPcC8FLZOONqQD06wWtZa8FeiK4lX</recordid><startdate>20030601</startdate><enddate>20030601</enddate><creator>MUNIR, Muhammad A</creator><creator>JAFFAR, Muhammad</creator><creator>ARSHAD, Muhammad</creator><creator>AKHTER, M. Shahab</creator><creator>JUNMING ZHANG</creator><general>Canadian Anesthesiologists' Society</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20030601</creationdate><title>Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient</title><author>MUNIR, Muhammad A ; JAFFAR, Muhammad ; ARSHAD, Muhammad ; AKHTER, M. Shahab ; JUNMING ZHANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c376t-56d90979aba6b378d86263c49a045e26cc891859675b0911a3db65a770da4c743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Androstanols - pharmacology</topic><topic>Anesthesia</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Muscle Relaxation - drug effects</topic><topic>Neuromuscular Nondepolarizing Agents - pharmacology</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Receptors, Cholinergic - analysis</topic><topic>Receptors, Cholinergic - drug effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MUNIR, Muhammad A</creatorcontrib><creatorcontrib>JAFFAR, Muhammad</creatorcontrib><creatorcontrib>ARSHAD, Muhammad</creatorcontrib><creatorcontrib>AKHTER, M. Shahab</creatorcontrib><creatorcontrib>JUNMING ZHANG</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business &amp; Current Affairs Database</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Canadian journal of anesthesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MUNIR, Muhammad A</au><au>JAFFAR, Muhammad</au><au>ARSHAD, Muhammad</au><au>AKHTER, M. Shahab</au><au>JUNMING ZHANG</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient</atitle><jtitle>Canadian journal of anesthesia</jtitle><addtitle>Can J Anaesth</addtitle><date>2003-06-01</date><risdate>2003</risdate><volume>50</volume><issue>6</issue><spage>558</spage><epage>561</epage><pages>558-561</pages><issn>0832-610X</issn><eissn>1496-8975</eissn><coden>CJOAEP</coden><abstract>To report a case of reduced duration of action of rocuronium in a patient with normocalcemic hyperparathyroidism (HPT). A 56-yr-old patient with primary HPT, who had had surgical resection of three and a half parathyroid glands nine months previously, was referred to our institution for further investigation of a persistent increase in parathyroid hormone. Preoperatively, the patient had a normal serum ionized and total calcium. The patient was diagnosed with a persistent parathyroid adenoma and was scheduled for an elective parathyroidectomy. General anesthesia was induced with iv propofol, fentanyl and succinylcholine. Intraoperatively, anesthesia was maintained with nitrous oxide in oxygen, and isoflurane. Neuromuscular blockade was attained using incremental doses of rocuronium. The average duration of 0.15 mg x kg(-1) incremental doses of rocuronium was 5.9 min (expected: 13-18 min), and that of 0.2 mg x kg(-1) was ten minutes (expected: 19-23 min). Primary HPT even in the absence of hypercalcemia may result in resistance to competitive blockade by rocuronium. It suggests that primary HPT may cause acetylcholine receptor up-regulation resulting in hyposensitivity to non-depolarizing muscle relaxants.</abstract><cop>Toronto, ON</cop><pub>Canadian Anesthesiologists' Society</pub><pmid>12826546</pmid><doi>10.1007/BF03018640</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0832-610X
ispartof Canadian journal of anesthesia, 2003-06, Vol.50 (6), p.558-561
issn 0832-610X
1496-8975
language eng
recordid cdi_proquest_miscellaneous_73400155
source MEDLINE; SpringerLink Journals
subjects Androstanols - pharmacology
Anesthesia
Anesthetics. Neuromuscular blocking agents
Biological and medical sciences
Female
Humans
Medical sciences
Middle Aged
Muscle Relaxation - drug effects
Neuromuscular Nondepolarizing Agents - pharmacology
Neuropharmacology
Pharmacology. Drug treatments
Receptors, Cholinergic - analysis
Receptors, Cholinergic - drug effects
Time Factors
title Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T11%3A39%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20duration%20of%20muscle%20relaxation%20with%20rocuronium%20in%20a%20normocalcemic%20hyperparathyroid%20patient&rft.jtitle=Canadian%20journal%20of%20anesthesia&rft.au=MUNIR,%20Muhammad%20A&rft.date=2003-06-01&rft.volume=50&rft.issue=6&rft.spage=558&rft.epage=561&rft.pages=558-561&rft.issn=0832-610X&rft.eissn=1496-8975&rft.coden=CJOAEP&rft_id=info:doi/10.1007/BF03018640&rft_dat=%3Cproquest_cross%3E73400155%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=881375157&rft_id=info:pmid/12826546&rfr_iscdi=true